Concomitant Intravenous Nitroglycerin With Intracoronary Delivery of AAV1.SERCA2a Enhances Gene Transfer in Porcine Hearts

This publication has 33 references indexed in Scilit:

• Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID)
  Circulation, 2011
• Cardiac gene therapy with SERCA2a: From bench to bedside
  Journal of Molecular and Cellular Cardiology, 2011
• Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical Trial
  Journal of Cardiac Failure, 2009
• The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases
  Nature Clinical Practice Cardiovascular Medicine, 2008
• Design of a Phase 1/2 Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Heart Failure
  Journal of Cardiac Failure, 2008
• Reversal of Cardiac Dysfunction After Long-Term Expression of SERCA2a by Gene Transfer in a Pre-Clinical Model of Heart Failure
  JACC, 2008
• Vasodilators in the management of acute heart failure
  Critical Care Medicine, 2008
• Restoration of impaired endothelium-dependent coronary vasodilation in failing heart: role of eNOS phosphorylation and CGMP/cGK-I signaling
  American Journal of Physiology-Heart and Circulatory Physiology, 2007
• Highly Efficient Adenovirus-Mediated Gene Transfer to Cardiac Myocytes after Single-Pass Coronary Delivery
  Human Gene Therapy, 2000
• Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure
  Proceedings of the National Academy of Sciences, 2000